Trade IDEXX Laboratories, Inc. - IDXX CFD
Add to favourite- Summary
- Historical Data
| Spread | 1.44 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001124% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 0.1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 420.27 |
| Open | 410.31 |
| 1-Year Change | -22.45% |
| Day's Range | 410.31 - 420.13 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Mar 21, 2025 | 419.62 | 7.47 | 1.81% | 412.15 | 421.51 | 407.60 |
| Mar 20, 2025 | 420.27 | -0.60 | -0.14% | 420.87 | 424.90 | 415.78 |
| Mar 19, 2025 | 420.17 | 4.39 | 1.06% | 415.78 | 423.79 | 415.53 |
| Mar 18, 2025 | 419.39 | -0.49 | -0.12% | 419.88 | 424.64 | 417.29 |
| Mar 17, 2025 | 421.83 | 7.95 | 1.92% | 413.88 | 424.18 | 413.88 |
| Mar 14, 2025 | 415.04 | 6.84 | 1.68% | 408.20 | 415.91 | 406.65 |
| Mar 13, 2025 | 406.12 | -4.25 | -1.04% | 410.37 | 415.56 | 403.27 |
| Mar 12, 2025 | 412.20 | -9.08 | -2.16% | 421.28 | 427.38 | 410.89 |
| Mar 11, 2025 | 426.46 | -11.20 | -2.56% | 437.66 | 439.26 | 424.97 |
| Mar 10, 2025 | 436.27 | 10.50 | 2.47% | 425.77 | 446.84 | 425.77 |
| Mar 7, 2025 | 430.03 | 2.30 | 0.54% | 427.73 | 434.27 | 419.86 |
| Mar 6, 2025 | 428.59 | -1.31 | -0.30% | 429.90 | 438.46 | 426.60 |
| Mar 5, 2025 | 435.52 | -2.33 | -0.53% | 437.85 | 445.41 | 428.66 |
| Mar 4, 2025 | 442.86 | 8.55 | 1.97% | 434.31 | 448.46 | 431.98 |
| Mar 3, 2025 | 437.00 | 2.80 | 0.64% | 434.20 | 441.30 | 433.56 |
| Feb 28, 2025 | 435.05 | -3.13 | -0.71% | 438.18 | 440.95 | 422.30 |
| Feb 27, 2025 | 439.82 | -13.06 | -2.88% | 452.88 | 459.81 | 439.82 |
| Feb 26, 2025 | 457.75 | -0.13 | -0.03% | 457.88 | 464.64 | 453.99 |
| Feb 25, 2025 | 459.88 | -4.07 | -0.88% | 463.95 | 466.14 | 451.49 |
| Feb 24, 2025 | 462.30 | 9.74 | 2.15% | 452.56 | 464.69 | 450.54 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
IDEXX Labs Company profile
About IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services for the companion animal veterinary, livestock and poultry, dairy and water testing markets. It also sells a line of portable electrolytes and blood gas analyzers used in the human diagnostics market. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment CAG develops, designs, manufactures, and distributes products and performs services for veterinarians and the biomedical analytics market, primarily related to diagnostics and information management. The Water segment develops, designs, manufactures, and distributes a range of products used in the detection of various microbiological parameters in water. The LPD segment develops, designs, manufactures, and distributes diagnostic tests and related instrumentation and performs services that are used to manage the health status of livestock and poultry.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, IDEXX Laboratories, Inc. revenues increased 19% to $3.22B. Net income increased 28% to $744.8M. Revenues reflect CAG segment increase of 21% to $5.42B, Water segment increase of 14% to $146.5M, United States segment increase of 18% to $2B, Canada segment increase of 30% to $139.7M, Germany segment increase of 23% to $146.8M. Net income benefited from CAG segment income increase of 43% to $824M.
Equity composition
Common Stock $.10 Par, 06/11, 120M auth., 98,835,000 issd., less 42,004,000 shs. in Treas. @ $1.16B. Insiders control approx.1.09%. IPO: 4/92, 1.5M shares @ $20.50 by Lehman Brothers. PO: 10/95, 4.6M shares @ $35 by Cowen & Company. 11/07, 6/95 & 10/93, 2-for-1 stock splits. 06/15, 2-for-1, Stock Split.
| Industry: | Veterinary Medical Equipment & Supplies |
One Idexx Drive
WESTBROOK
MAINE 04092-2041
US
News
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025
Coffee price forecast: 2025-2030 third-party coffee target
Coffee prices have cooled considerably in the past few months. Is a rebound in store or will they continue to fall?
09:42, 12 March 2025
The Simpsons predicted XRP to hit $589: Has the show got it right again?
Did the animated TV show predict a breakout for the XRP cryptocurrency?
11:00, 11 March 2025
Rolls-Royce share price forecast: third- party price target
Our Rolls-Royce share price forecast looks at the outlook for the FTSE 100-listed engineering company after a tough few years.
14:58, 10 March 2025
Gasoline petrol price forecast 2025-2030: Third-party price target
Discover third-party gasoline (petrol) price predictions for 2025 and beyond, with analyst targets, historical prices, and trading strategies.
10:27, 3 March 2025
USD forecast - third party data round up
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
10:02, 27 February 2025
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025People also watch
Still looking for a broker you can trust?
Join the 700,000+ traders worldwide that chose to trade with Capital.com